Form 4: Organon & Co. Executive Acquires and Disposes of Shares Following PSU Vesting

Vittorio Nisita, Head of Global Business Services at Organon & Co., reports transactions involving Organon common stock, including acquisitions from performance share unit (PSU) vesting and dividend equivalents, as well as dispositions to cover tax obligations.

Summary

• On February 20, 2025, Vittorio Nisita, Head of Global Business Services at Organon & Co., reported transactions involving the company's common stock.
• These transactions include the acquisition of 11,229 shares related to the vesting of performance share units (PSUs) granted on August 09, 2022, under the company's 2021 Incentive Stock Plan.
• The performance-vesting restrictions were released upon certification of performance goal attainment by the Talent Committee of Organon's Board of Directors.
• Additionally, 2,056 shares were acquired to cover dividend equivalents earned on the released PSUs.
• Nisita also disposed of 4,211 shares at $14.92 and 705 shares at $15.29 to cover tax obligations.
• The report also notes the addition of 2,006.539 shares acquired from dividend reinvestments not previously reported.
• Following these transactions, Nisita beneficially owns 35,123.539 shares of Organon & Co. common stock.

Sentiment

Score: 6

Explanation: The document reflects routine transactions related to executive compensation. The vesting of PSUs suggests positive performance, but the subsequent sale of shares is neutral. Overall, the sentiment is moderately positive due to the achievement of performance goals.

Positives

• The vesting of performance share units indicates that performance goals set by the company were achieved, as certified by the Talent Committee of Organon's Board of Directors.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and their holdings in the company's stock. This filing reflects standard compensation practices involving stock-based awards and their subsequent vesting and tax-related dispositions.

Comparison to Industry Standards

• Stock-based compensation, including performance share units (PSUs), is a common practice among publicly traded companies to align executive incentives with shareholder value.
• The vesting of PSUs upon achievement of performance goals is a standard mechanism to reward executives for meeting pre-defined targets.
• Companies like Pfizer, Merck, and Johnson & Johnson also utilize similar stock-based compensation plans for their executives.
• The reporting of these transactions via Form 4 is mandated by the SEC to ensure transparency and prevent insider trading, aligning with regulatory standards across the industry.

Stakeholder Impact

• The vesting of performance share units and subsequent transactions may have a minor impact on shareholders, reflecting the alignment of executive compensation with company performance.
• Employees may view the vesting of PSUs as a positive sign of the company's performance and the achievement of its goals.

Key Dates

Keywords

Organon & Co., Vittorio Nisita, Form 4, Beneficial Ownership, Performance Share Units, PSUs, Dividend Equivalents, Stock Transactions, Incentive Stock Plan